Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

TMCI

Treace Medical Concepts Inc

Dec 08 • 04:00PM ET

9.50

Dollar change +0.03
Percentage change 0.32	%

Healthcare • Medical Devices • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.79	Insider Own	29.08%	Shs Outstand	55.63M	Perf Week	2.04%
Market Cap	585.96M	Forward P/E	-	EPS next Y	-0.63	Insider Trans	0.00%	Shs Float	43.74M	Perf Month	-11.38%
Income	-47.66M	PEG	-	EPS next Q	-0.10	Inst Own	62.41%	Short Float / Ratio	8.63% / 3.73	Perf Quarter	-33.10%
Sales	174.68M	P/S	3.35	EPS this Y	-16.63%	Inst Trans	10.95%	Short Interest	3.77M	Perf Half Y	-63.29%
Book/sh	2.24	P/B	4.25	EPS next Y	21.14%	ROA	-24.02%	Target Price	13.29	Perf Year	-60.78%
Cash/sh	1.98	P/C	4.80	EPS next 5Y	-	ROE	-47.64%	52W Range	5.27 - 27.97	Perf YTD	-58.68%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-23.00%	52W High	-66.04%	Beta	0.06
Dividend %	-	Quick Ratio	4.76	Sales past 5Y	53.45%	Gross Margin	80.85%	52W Low	80.27%	ATR	0.69
Employees	423	Current Ratio	5.64	Sales Q/Q	23.30%	Oper. Margin	-27.56%	RSI (14)	52.48	Volatility	6.20% 8.79%
Optionable	Yes	Debt/Eq	0.51	EPS Q/Q	-30.01%	Profit Margin	-27.28%	Rel Volume	0.62	Prev Close	9.47
Shortable	Yes	LT Debt/Eq	0.50	Earnings	Nov 09 AMC	Payout	-	Avg Volume	1.01M	Price	9.50
Recom	1.29	SMA20	11.66%	SMA50	-4.24%	SMA200	-50.65%	Volume	622,953	Change	0.32%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-29-23	Initiated	UBS	Buy	$24
May-01-23	Initiated	Truist	Buy	$33
Apr-11-23	Initiated	Stephens	Equal-Weight	$26
May-12-22	Initiated	BTIG Research	Buy	$22
Jan-07-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$30
May-18-21	Initiated	SVB Leerink	Outperform	$38
May-18-21	Initiated	Stifel	Buy	$35
May-18-21	Initiated	Morgan Stanley	Equal-Weight	$30
May-18-21	Initiated	JP Morgan	Overweight	$37

Dec-07-23 06:27AM	Does the New Anti-Obesity Medicine Affect Treace Medical Concepts (TMCI)? (Insider Monkey) +6.29%
Nov-12-23 12:22PM	Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-10-23 09:13AM	Q3 2023 Treace Medical Concepts Inc Earnings Call (Thomson Reuters StreetEvents) -37.90%
Nov-09-23 05:28PM	Treace Medical Concepts: Q3 Earnings Snapshot (Associated Press Finance) -6.72%
04:05PM	Treace Medical Concepts Reports Third Quarter 2023 Financial Results (GlobeNewswire)
07:00AM	Loading…
Oct-30-23 07:00AM	Treace to Present at Stifel 2023 Healthcare Conference (GlobeNewswire)
Oct-16-23 07:00AM	Treace to Report Third Quarter 2023 Financial Results (GlobeNewswire)
Sep-20-23 07:00AM	Treace Highlights New Product Innovations and Updated ALIGN3D Clinical Study Data at the American Orthopaedic Foot & Ankle Society Annual Meeting 2023 (GlobeNewswire)
Sep-14-23 04:05PM	Treace Medical Concepts Announces New Patent Covering Instrumented Bunion Correction Procedures and Milestone 50th U.S. Patent (GlobeNewswire)
Sep-11-23 04:05PM	Treace Medical Concepts Announces Limited Market Release of New Complementary Technologies for Treating Bunions and Related Procedures (GlobeNewswire)
Aug-22-23 04:05PM	Treace Announces Participation in the 21st Annual Morgan Stanley Global Healthcare Conference (GlobeNewswire)
Aug-21-23 07:00AM	Treace Medical Concepts Appoints Nathan Minnich as Senior Vice President, Marketing (GlobeNewswire) -9.09%
Aug-08-23 06:30PM	Treace Medical Concepts (TMCI) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
05:27PM	Treace Medical Concepts: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Treace Medical Concepts Reports Second Quarter 2023 Financial Results (GlobeNewswire)
04:05PM	Loading…
Jul-24-23 04:05PM	Treace Announces Participation in the UBS Medtech, Tools and Genomics Summit 2023 (GlobeNewswire) -7.71%
Jul-18-23 04:15PM	Treace to Report Second Quarter 2023 Financial Results on August 8, 2023 (GlobeNewswire)
Jul-12-23 04:15PM	Treace Appoints Julie Dewey as Chief Communications and Investor Relations Officer (GlobeNewswire)
Jul-10-23 08:03AM	While Treace Medical Concepts (NASDAQ:TMCI) shareholders have made 43% in 1 year, increasing losses might now be front of mind as stock sheds 5.0% this week (Simply Wall St.)
Jun-13-23 04:15PM	Treace Medical Completes Acquisition of Technology Enabling Patient Specific Instrumentation and Reports on Clinical Cases Using PSI with the Lapiplasty® System (GlobeNewswire)
Jun-12-23 07:02AM	Daily Vickers Top Buyers & Sellers for 06/12/2023 (Argus Research)
Jun-05-23 07:56AM	Treace Medical Concepts, Inc. (NASDAQ:TMCI) is largely controlled by institutional shareholders who own 58% of the company (Simply Wall St.)
Jun-01-23 04:15PM	Treace Medical Concepts to Acquire Technology Enabling Patient Specific Instrumentation for Foot and Ankle Surgeries (GlobeNewswire)
May-09-23 09:38AM	Q1 2023 Treace Medical Concepts Inc Earnings Call (Thomson Reuters StreetEvents)
07:10AM	Calculating The Fair Value Of Treace Medical Concepts, Inc. (NASDAQ:TMCI) (Simply Wall St.)
May-08-23 05:55PM	Treace Medical Concepts (TMCI) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:55PM	Treace Medical Concepts: Q1 Earnings Snapshot (AP Finance)
04:05PM	Treace Medical Concepts Reports First Quarter 2023 Financial Results (GlobeNewswire)
Apr-26-23 04:15PM	Treace Announces Participation in the Bank of America 2023 Healthcare Conference (GlobeNewswire)
Apr-20-23 04:15PM	Treace to Report First Quarter 2023 Financial Results on May 8, 2023 (GlobeNewswire)
04:15PM	Loading…
Apr-19-23 04:15PM	Treace Medical Expands Market Leading Global IP Portfolio For Bunion And Related Deformities (GlobeNewswire)
Apr-18-23 10:14AM	Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) P/S Is On The Mark (Simply Wall St.)
Apr-10-23 07:58AM	Treace Medical Concepts (TMCI) Surges 7.6%: Is This an Indication of Further Gains? (Zacks)
Apr-04-23 04:15PM	Treace Publishes Inaugural ESG Report (GlobeNewswire)
Mar-14-23 02:11PM	'Dodged a bullet': How fall of SVB is affecting First Coast companies (American City Business Journals)
Mar-08-23 03:50PM	Why Treace Medical Concepts' Shares Rose Wednesday (Motley Fool) +21.11%
08:12AM	Q4 2022 Treace Medical Concepts Inc Earnings Call (Thomson Reuters StreetEvents)
02:07AM	Ponte Vedra-based Treace posts $4.4M loss for Q4, beating analysts expectations (American City Business Journals)
Mar-07-23 04:05PM	Treace Medical Concepts Reports Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire)
Mar-03-23 09:03AM	Treace Medical Announces Settlement of Lawsuit Against Fusion Orthopedics (GlobeNewswire)
09:03AM	Treace Medical Announces Settlement of Lawsuit Again Fusion Orthopedics (GlobeNewswire)
Feb-27-23 04:15PM	Treace to Report Fourth Quarter and Full Year 2022 Financial Results on March 7, 2023 (GlobeNewswire)
Feb-09-23 01:00PM	Treace Presents Updated ALIGN3D Interim Data and Latest Product Innovations at the 2023 ACFAS Annual Conference (GlobeNewswire)
Feb-07-23 09:15PM	Treace Medical Concepts, Inc. Announces Pricing of $100.0 Million Public Offering of Common Stock (GlobeNewswire)
04:30PM	Treace Medical Concepts, Inc. Announces Proposed Public Offering of Common Stock (GlobeNewswire)
Jan-31-23 05:09AM	Despite currently being unprofitable, Treace Medical Concepts (NASDAQ:TMCI) has delivered a 25% return to shareholders over 1 year (Simply Wall St.)
Jan-09-23 08:00AM	Treace Medical Concepts Provides 2022 Preliminary Unaudited Revenue (GlobeNewswire)
Dec-21-22 05:52AM	Owning 47% shares,institutional owners seem interested in Treace Medical Concepts, Inc. (NASDAQ:TMCI), (Simply Wall St.)
Dec-20-22 04:15PM	Treace to Present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023 (GlobeNewswire)
Dec-19-22 04:15PM	Treace Medical Announces Expansion of Its Global IP Portfolio with the Grant of Two New U.S. Patents (GlobeNewswire)
08:50AM	Recent Price Trend in Treace Medical Concepts (TMCI) is Your Friend, Here's Why (Zacks)
Dec-01-22 08:50AM	Treace Medical Concepts (TMCI) is on the Move, Here's Why the Trend Could be Sustainable (Zacks) +6.57%
Nov-28-22 04:15PM	Treace Receives FDA 510(k) Clearance for SpeedPlate Rapid Compression Implant Technology (GlobeNewswire)
Nov-21-22 04:15PM	Treace Announces First Patient Treated in MTA3D Adductoplasty® Clinical Study (GlobeNewswire)
Nov-14-22 08:50AM	Here's What Could Help Treace Medical Concepts (TMCI) Maintain Its Recent Price Strength (Zacks)
Nov-10-22 05:50AM	Treace Medical Concepts Third Quarter 2022 Earnings: Beats Expectations (Simply Wall St.) +10.06%
Nov-08-22 07:15PM	Treace Medical Concepts (TMCI) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Treace Medical Concepts Reports Third Quarter 2022 Financial Results (GlobeNewswire)
Oct-29-22 09:10AM	Bullish insiders at Treace Medical Concepts, Inc. (NASDAQ:TMCI) loaded up on US$1.3m of stock earlier this year (Simply Wall St.)
Oct-25-22 04:15PM	Treace Announces Participation in Upcoming Investor Conferences (GlobeNewswire)
Oct-18-22 04:15PM	Treace to Report Third Quarter 2022 Financial Results on November 8, 2022 (GlobeNewswire) +5.16%
Sep-27-22 04:15PM	Treace Medical Concepts Appoints New Directors (GlobeNewswire)
Sep-14-22 08:06AM	Treace Medical Shares Interim Data From Corrective Toe Surgery Trial (Benzinga) +8.28%
Sep-13-22 04:15PM	Treace Highlights New Product Innovations at the 2022 AOFAS Scientific Conference (GlobeNewswire)
04:05PM	Treace Announces Updated ALIGN3D Data at the 2022 AOFAS Annual Meeting (GlobeNewswire)
Sep-12-22 10:38AM	Strength Seen in Treace Medical Concepts (TMCI): Can Its 8.4% Jump Turn into More Strength? (Zacks)
Aug-24-22 04:15PM	Treace Announces Participation in the Morgan Stanley 20th Annual Global Healthcare Conference (GlobeNewswire) +5.32%
Aug-13-22 08:31AM	Earnings Update: Treace Medical Concepts, Inc. (NASDAQ:TMCI) Just Reported Its Second-Quarter Results And Analysts Are Updating Their Forecasts (Simply Wall St.)
Aug-09-22 10:00PM	Treace Medical Concepts, Inc. (TMCI) Q2 2022 Earnings Call Transcript (Motley Fool) -5.78%
09:44PM	Treace Medical posts $17 million loss as expenses and sales surge (American City Business Journals)
06:55PM	Treace Medical Concepts (TMCI) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Treace Medical Concepts Reports Second Quarter 2022 Financial Results (GlobeNewswire)
Aug-03-22 04:15PM	Treace Announces Full Commercial Release of New Technologies for Bunion and Related Midfoot Surgery (GlobeNewswire) +5.30%
Jul-25-22 04:30PM	Treace to Host Surgeon Advisor Event on September 20, 2022 (GlobeNewswire)
Jul-22-22 08:30AM	Treace to Report Second Quarter 2022 Financial Results on August 9, 2022 (GlobeNewswire)
Jul-18-22 07:45AM	Sensus Healthcare, Inc. (SRTS) Soars 8.7%: Is Further Upside Left in the Stock? (Zacks) -5.16%
Jul-05-22 01:12AM	As stocks plunge, Jacksonville public companies have dismal first half of the year (American City Business Journals)
Jun-28-22 06:37AM	What Type Of Shareholders Make Up Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) Share Registry? (Simply Wall St.)
Jun-20-22 07:48AM	Treace Medical Concepts (TMCI) Moves 8.2% Higher: Will This Strength Last? (Zacks)
Jun-16-22 02:03PM	On verge of moving into a bigger headquarters, here's how Treace Medical is pursuing growth (American City Business Journals) -7.55%
May-22-22 08:31AM	Mark Hair Is The Chief Financial Officer of Treace Medical Concepts, Inc. (NASDAQ:TMCI) And They Just Picked Up 46% More Shares (Simply Wall St.)
May-19-22 11:01AM	Loss-making Treace Medical Concepts (NASDAQ:TMCI) has seen earnings and shareholder returns follow the same downward trajectory over past -51% (Simply Wall St.)
May-06-22 09:01AM	Treace Medical Concepts, Inc. (TMCI) Q1 2022 Earnings Call Transcript (Motley Fool) -9.38%
May-05-22 06:25PM	Treace Medical Concepts (TMCI) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -5.56%
05:51PM	Treace Medical posts $9 million loss as expenses outpace sales (American City Business Journals)
04:05PM	Treace Medical Concepts Reports First Quarter 2022 Financial Results (GlobeNewswire)
08:15AM	Treace Announces Peer-Reviewed Publication of ALIGN3D Multicenter Prospective Clinical Data (GlobeNewswire)
May-02-22 08:00AM	Treace Secures Up to $150 Million in Debt Financing (GlobeNewswire)
Apr-14-22 04:15PM	Treace to Report First Quarter 2022 Financial Results on May 5, 2022 (GlobeNewswire)
Mar-28-22 04:15PM	Treace Files Patent Infringement Suit To Protect Lapiplasty® Bunion Technology (GlobeNewswire)
Mar-04-22 12:00AM	Treace Medical Concepts, Inc. (TMCI) Q4 2021 Earnings Call Transcript (Motley Fool)
Mar-03-22 04:05PM	Treace Medical Concepts Reports Fourth Quarter and Full Year 2021 Financial Results (GlobeNewswire)
Feb-25-22 12:15PM	Treace Announces Updated ALIGN3D Data at the 2022 ACFAS Scientific Conference (GlobeNewswire)
Feb-23-22 04:15PM	Treace Highlights New Product Innovations at the 2022 ACFAS Scientific Conference (GlobeNewswire)
Feb-14-22 04:15PM	Treace to Report Fourth Quarter and Full Year 2021 Financial Results on March 3, 2022 (GlobeNewswire)
Feb-08-22 02:38PM	Fwl Investment Management, Llc Buys E2open Parent Holdings Inc, Cheniere Energy Inc, SPDR ... (GuruFocus.com)
Feb-01-22 04:15PM	Treace to Announce Latest ALIGN3D Data at the 2022 ACFAS Scientific Conference (GlobeNewswire)
Jan-28-22 01:38PM	Roubaix Capital, LLC Buys Treace Medical Concepts Inc, Alpha Teknova Inc, EnerSys, Sells Rogers ... (GuruFocus.com)
Jan-19-22 04:15PM	Treace Announces Grant of U.S. Patent on Instrumented Bunion Correction (GlobeNewswire)
09:22AM	Here's What Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) Shareholder Ownership Structure Looks Like (Simply Wall St.)

Treace Medical Concepts, Inc. engages in the design, manufacture, and marketing of orthopedic medical devices and biologic solutions. It offers Lapiplasty, a bunion surgery for three-dimensional bunion correction. It operates and distributes its products and services under the following trademarks: Treace Medical Concepts, Lapiplasty, Fast Grafter, Align My Toe, The Future of Hallux Valgus, Fix It Right The First Time, and Plantar Python. The company was founded by John T. Treace in July 2013 and is headquartered in Ponte Vedra Beach, FL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BAYS F BARRY	Former Director	Jun 05	Sale	26.51	1,042,318	27,631,850	0	Jun 08 04:28 PM
BAYS F BARRY	Former Director	Jun 02	Sale	26.51	48,503	1,285,815	1,042,318	Jun 08 04:28 PM
Scanlan Sean F.	Chief Innovation Officer	May 16	Option Exercise	0.10	25,000	2,500	57,395	May 18 09:00 PM
Scanlan Sean F.	Chief Innovation Officer	May 16	Sale	25.44	25,000	635,978	32,395	May 18 09:00 PM
TREACE JAMES T	Director	May 01	Sale	25.24	10,000	252,431	861,441	May 02 09:00 PM
TREACE JAMES T	Director	Apr 28	Sale	25.01	40,000	1,000,264	871,441	May 02 09:00 PM
BAYS F BARRY	Director	Apr 27	Sale	25.35	11,600	294,031	1,090,821	Apr 28 09:00 PM
BAYS F BARRY	Director	Apr 26	Sale	25.55	16,204	414,012	1,102,421	Apr 28 09:00 PM
BAYS F BARRY	Director	Apr 12	Sale	26.12	36,370	950,104	1,118,625	Apr 13 09:00 PM
BAYS F BARRY	Director	Apr 11	Sale	26.38	49,790	1,313,394	1,154,995	Apr 13 09:00 PM
MOTT RICHARD W	Director	Apr 06	Sale	26.00	4,043	105,121	905,000	Apr 10 09:00 PM
MOTT RICHARD W	Director	Apr 04	Sale	26.00	15,756	409,667	909,043	Apr 05 09:00 PM
MOTT RICHARD W	Director	Apr 03	Sale	26.00	201	5,226	924,799	Apr 05 09:00 PM
MOTT RICHARD W	Director	Mar 31	Sale	25.36	95,000	2,409,029	925,000	Mar 31 09:00 PM
TREACE JAMES T	Director	Mar 30	Sale	25.86	50,000	1,293,170	911,441	Mar 31 09:00 PM
MOTT RICHARD W	Director	Mar 30	Sale	26.00	38,498	1,000,998	1,020,000	Mar 31 09:00 PM
BAYS F BARRY	Director	Mar 29	Sale	25.28	32,457	820,425	1,204,785	Mar 30 09:00 PM
BAYS F BARRY	Director	Mar 28	Sale	25.02	26,241	656,650	1,237,242	Mar 30 09:00 PM
Owens Daniel E.	Chief Human Resources Officer	Mar 15	Option Exercise	7.03	6,250	43,925	37,164	Mar 17 09:00 PM
TIMBIE THOMAS E	Director	Mar 15	Sale	23.03	50,000	1,151,665	1,149,069	Mar 17 09:00 PM
Owens Daniel E.	Chief Human Resources Officer	Mar 15	Sale	22.87	6,250	142,956	30,914	Mar 17 09:00 PM
BAYS F BARRY	Director	Mar 14	Sale	23.25	9,400	218,533	1,263,483	Mar 15 09:00 PM
BAYS F BARRY	Director	Mar 13	Sale	24.15	9,400	226,997	1,272,883	Mar 15 09:00 PM
Treace John T.	Chief Executive Offer	Mar 09	Sale	24.41	2,075	50,651	5,539,380	Mar 10 09:00 PM
MOTT RICHARD W	Director	Mar 09	Sale	26.00	1,502	39,052	1,058,498	Mar 10 09:00 PM
Hair Mark	Chief Financial Officer	Mar 09	Sale	24.41	1,040	25,386	27,110	Mar 10 09:00 PM
Berutti Aaron	Sr. VP, Sales	Mar 09	Sale	24.41	733	17,893	13,042	Mar 10 09:00 PM
Scanlan Sean F.	Chief Innovation Officer	Mar 09	Sale	24.41	505	12,327	9,470	Mar 10 09:00 PM
Owens Daniel E.	Chief Human Resources Officer	Mar 09	Sale	24.41	411	10,033	10,289	Mar 10 09:00 PM
Elder Scot Michael	*See "Remarks"	Mar 09	Sale	24.41	177	4,321	22,421	Mar 10 09:00 PM
MOTT RICHARD W	Director	Mar 08	Sale	23.17	45,000	1,042,502	1,060,000	Mar 10 09:00 PM
MOTT RICHARD W	Director	Mar 01	Sale	21.35	50,000	1,067,545	1,105,000	Mar 03 09:00 PM
TREACE JAMES T	Director	Mar 01	Sale	21.36	12,684	270,930	961,441	Mar 02 09:00 PM
TREACE JAMES T	Director	Feb 28	Sale	21.54	37,316	803,787	974,125	Mar 02 09:00 PM
BAYS F BARRY	Director	Feb 22	Sale	21.97	9,400	206,535	1,282,283	Feb 23 09:00 PM
BAYS F BARRY	Director	Feb 21	Sale	21.74	9,400	204,352	1,291,683	Feb 23 09:00 PM
Scanlan Sean F.	Chief Innovation Officer	Feb 15	Option Exercise	0.10	25,000	2,500	34,975	Feb 17 09:00 PM
TIMBIE THOMAS E	Director	Feb 15	Sale	21.71	50,000	1,085,350	1,199,069	Feb 17 05:52 PM
Scanlan Sean F.	Chief Innovation Officer	Feb 15	Sale	21.69	25,000	542,235	9,975	Feb 17 09:00 PM
BAYS F BARRY	Director	Feb 08	Sale	21.70	27,731	601,901	1,301,083	Feb 09 09:00 PM
BAYS F BARRY	Director	Feb 07	Sale	23.00	8,800	202,367	1,328,814	Feb 09 09:00 PM
MOTT RICHARD W	Director	Feb 02	Sale	24.00	4,011	96,264	1,155,000	Feb 03 09:00 PM
TREACE JAMES T	Director	Jan 31	Sale	23.19	11,929	276,634	1,011,441	Feb 02 09:00 PM
MOTT RICHARD W	Director	Jan 30	Sale	23.25	90,989	2,115,171	1,159,011	Jan 30 06:30 PM
TREACE JAMES T	Director	Jan 30	Sale	23.20	38,071	883,092	1,023,370	Jan 30 06:35 PM
BAYS F BARRY	Director	Jan 25	Sale	25.40	27,722	704,099	1,337,614	Jan 26 09:13 PM
BAYS F BARRY	Director	Jan 24	Sale	26.03	25,921	674,744	1,365,336	Jan 26 09:13 PM
TIMBIE THOMAS E	Director	Jan 18	Sale	25.88	50,000	1,294,000	1,249,069	Jan 20 09:00 PM
MOTT RICHARD W	Director	Jan 17	Sale	26.00	11,014	286,377	1,250,000	Jan 19 09:00 PM
MOTT RICHARD W	Director	Jan 13	Sale	26.00	6,519	169,495	1,261,014	Jan 13 09:00 PM
Scanlan Sean F.	Chief Innovation Officer	Jan 12	Option Exercise	0.10	25,000	2,500	34,975	Jan 13 09:00 PM
BAYS F BARRY	Director	Jan 12	Sale	25.52	45,536	1,162,139	1,391,257	Jan 13 09:00 PM
MOTT RICHARD W	Director	Jan 12	Sale	26.00	42,467	1,104,167	1,267,533	Jan 13 09:00 PM
Scanlan Sean F.	Chief Innovation Officer	Jan 12	Sale	25.57	25,000	639,308	9,975	Jan 13 09:00 PM
BAYS F BARRY	Director	Jan 11	Sale	24.32	9,719	236,366	1,436,793	Jan 13 09:00 PM
MOTT RICHARD W	Director	Jan 09	Sale	24.00	10,444	250,677	1,310,000	Jan 09 09:00 PM
MOTT RICHARD W	Director	Jan 05	Sale	24.00	9,556	229,363	1,320,444	Jan 09 09:00 PM
MOTT RICHARD W	Director	Dec 30	Sale	22.67	75,000	1,700,422	1,330,000	Dec 30 09:00 PM
BAYS F BARRY	Director	Dec 20	Sale	23.24	9,414	218,777	1,481,333	Dec 21 09:00 PM
BAYS F BARRY	Director	Dec 19	Sale	22.86	9,067	207,264	1,490,747	Dec 21 09:00 PM
TIMBIE THOMAS E	Director	Dec 14	Sale	24.00	50,000	1,199,935	1,299,069	Dec 16 09:00 PM
TREACE JAMES T	Director	Dec 12	Sale	24.18	25,000	604,575	1,061,441	Dec 14 09:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

TMCI

Treace Medical Concepts Inc

Upgrade your FINVIZ experience